CIK 0001699382
- Non-accelerated filer
- Smaller reporting company
PMV Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PMVP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463218129
- Phone
- +1 609-642-6670
- Business address
- 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-29 | Thompson Peter A. Director | Conversion · Series A Preferred Stock | −4,025,076 | 0 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion · Series B Preferred Stock | −1,076,891 | 0 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion · Series C Preferred Stock | −518,191 | 0 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion · Series D Preferred Stock | −380,133 | 0 | ||
| 2020-09-29 | Thompson Peter A. Director | Conversion · Series D Preferred Stock | −114,039 | 0 | ||
| 2020-09-29 | Schroeder Thilo Director | Conversion | +1,768,023 | 1,768,023 | ||
| 2020-09-29 | Schroeder Thilo Director | Conversion | +760,267 | 2,528,290 | ||
| 2020-09-29 | Schroeder Thilo Director | Conversion · Series C Preferred Stock | −1,768,023 | 0 | ||
| 2020-09-29 | Schroeder Thilo Director | Conversion · Series D Preferred Stock | −760,267 | 0 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion | +1,620,101 | 1,675,101 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion | +3,488,398 | 5,163,499 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion | +1,040,654 | 6,204,153 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion | +265,203 | 6,469,356 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion · Series Seed Preferred Stock | −1,620,101 | 0 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion · Series A Preferred Stock | −3,488,398 | 0 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion · Series B Preferred Stock | −1,040,654 | 0 | ||
| 2020-09-29 | INTERWEST PARTNERS X LP 10% owner | Conversion · Series C Preferred Stock | −265,203 | 0 | ||
| 2020-09-29 | ORONSKY ARNOLD L Director | Conversion | +1,620,101 | 1,675,101 | ||
| 2020-09-29 | ORONSKY ARNOLD L Director | Conversion | +3,488,398 | 5,163,499 | ||
| 2020-09-29 | ORONSKY ARNOLD L Director | Conversion | +1,040,654 | 6,204,153 |
Page 22 of 23 · 457 trades